Speakers
Angioedema

About Raffi Tachdjian
Email UCLAdoc@gmail.com Main Office Allergy, Immunology, Rare Diseases (ACARE Center), Raffi Tachdjian MD, Inc., 1301 20th Street, Suite 380, Santa Monica, CA 90404 Main Office Phone 310-998-0060 Main Office Fax 310-998-0063 Main Office Website www.DocRaffi.com Second Office UCLA Ronald Reagan Hospital and Clinics, Allergy, Immunology and Rheumatology Division, 200 Medical Plaza Driveway, Suite 265, Los Angeles, CA 90095 Second Office Phone 310-998-0060 Second Office Website https://www.uclahealth.org/providers/raffi-tachdjian Education 2004-2007 David Geffen School of Medicine at UCLA; Mattel Children’s Hospital, UCLA Medical Center, Los Angeles, CA; Fellowship in Allergy, Immunology, and Rheumatology 2001-2004 Harvard Medical School; Massachusetts General Hospital, Boston, MA; Internship and Residency in Pediatrics 1997-2001 Morehouse School of Medicine; Grady Memorial Hospital, Atlanta, GA; M.D. Program 1994-1995 Centers for Disease Control & Prevention; National Immunization Program, Atlanta, GA; Association of Schools of Public Health Intern 1993-1994 University of Alabama at Birmingham; School of Public Health, Birmingham, AL; Masters of Public Health (MPH) in Epidemiology 1987-1992 University of California, Los Angeles; Los Angeles, CA; B.S. in Physiological Science Academic Appointments 2019-present Associate Clinical Professor in Pediatrics, Division of Allergy, Immunology & Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA 2017-present Chief, Division of Allergy & Immunology, Providence St. John’s Medical Center, Santa Monica, CA Publications 1 Centers for Disease Control and Prevention. Influenza and Pneumococcal Vaccination Coverage Levels Among Persons >65 Years-United States, 1973-1993. MMWR Morb Mortal Wkly Rep. 1995;44:506-515. 2 Guris D, Strebel PM, Tachdjian R, et al. Effectiveness of Pertussis Vaccination Using the Screening Method, United States, 1992-1994. J Infect Dis. 1997;176(2):456-63. 3 Centers for Disease Control and Prevention. Influenza and Pneumococcal Vaccination Levels Among Adults Aged >65 Years-United States, 1997. MMWR Morb Mortal Wkly Rep. 1998;47:797-802. 4 Guris D, Strebel PM, Bardenheier B, Tachdjian R, et al. Changing Epidemiology of Pertussis in the U.S. Clin Infect Dis. 1999;28(6):1230-7. 5 Brennan M, Strebel P, George H, Yih KW, Tachdjian R, et al. Evidence for Transmission of Pertussis in Schools. J Infect Dis. 2000;181:210-5. 6 Vincent JM, Cherry JD, Nauschuetz WF, Lipton A, Ono CM, Costello CN, Sakaguchi LK, Hsue G, Jackson LA, Tachdjian R, et al. Prolonged Afebrile Nonproductive Cough Illnesses in American Soldiers in Korea. Clin Infect Dis. 2000;30(3):534-539. 7 Tachdjian R, Singleton J, Strikas RA, Williams WW, Baughman AL. Factors Associated with Influenza Vaccination Among Persons with Diabetes. 8 Phipatanakul W, Cronin B, Wood RA, Eggleston PA, Shih MC, Song L, Tachdjian R, Oettgen HC. Effect of environmental intervention on mouse allergen levels in homes of inner-city Boston children with asthma. Ann Allergy Asthma Immunol. 2004;92(4):420-5. 9 Chang AD, Tachdjian R, Gallagher K, McCurdy DK, Lassman C, Stiehm ER, Yadin O. Type III Mixed Cryoglobulinemia and Antiphospholipid Syndrome in a Patient with Partial DiGeorge Syndrome. Clin Dev Immunol. 2006;13(2-4):261-264. 10 Tachdjian R, Mathias C, Al Khatib S, Bryce PJ, Kim HS, Blaeser F, O’Connor BD, Rzymkiewicz D, Chen A, Holtzman MJ, Hershey GK, Garn H, Harb H, Renz H, Oettgen HC, Chatila TA. Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma. J Exp Med. 2009;206(10):2191-204. Specialty
Disclosures
Receipt of grants/research support: Adma, Kalvista Receipt of honoraria or consultation fee: BioCryst, CSL Behring, Ionis, Pharvaris, Kalvista, Intellia, Takeda

About Prof. Dr. Philip Li
–
Specialty
-
Disclosures
Receipt of honoraria or consultation fees: BioCryst Pharmaceuticals, CSL Behring, KalVista Pharmaceuticals, Pharvaris, Takeda

About Prof. Dr. Janina Hahn
–
Specialty
-
Disclosures
Receipt of grants/research supports: I received a grant of initiative researcher from Takeda Pharmaceuticals Other support:
Travel expenses/advisory boards/invited talks: Takeda Pharmaceuticals CSL Behring BioCryst Pharmaceutical Otsuka

About Prof. Dr. Henriette Farkas
Henriette Farkas is Professor of Allergology and Clinical Immunology at Semmelweis University, Budapest, Hungary. She serves as Director of the Hungarian Angioedema Center of Reference and Excellence (ACARE). She holds a Ph.D. in ENT, and the Hungarian Academy of Sciences awarded her a DSc in Clinical Immunology and Allergy.
She is a board member of the Committee of the Hungarian Allergology and Clinical Immunology Society and a member of the Regional Medical Advisory Panel (RMAP) of HAE International (HAEi), the International HAE Working Group, the World Allergy Organization Steering Committee for Angioedema, and the Steering Committee of ACARE. She also serves as Honorary President of the International Nurses Organization for HAE.
Professor Farkas founded the International C1 Inhibitor Deficiency and Angioedema Workshop and the Central-Eastern European HAENETWORK Project. She has supervised 52 student scientists and has been the tutor of 13 Ph.D. students.
Her research focuses on the different types of angioedema. She is a member of the editorial board of Frontiers in Allergy and has authored more than 600 scientific publications on angioedema.
Specialty
-
Disclosures
-

About Prof. Dr. Constance Katelaris
Professor Constance Katelaris is a leading allergist and immunologist based in Sydney. She serves as Professor of Immunology and Allergy at Western Sydney University and as Head of Department and Senior Staff Specialist at Campbelltown Hospital. In addition, she runs a private clinical practice, providing specialist care for children and adults with a wide range of allergic and immunologic conditions.
Professor Katelaris has held numerous leadership roles within professional societies, including presidencies of the Asia Pacific Association of Allergology, Asthma and Clinical Immunology and the Australasian Society of Clinical Immunology and Allergy. She has also been an active member of the World Allergy Organization Board.
Her academic interests include education and clinical research, particularly in ocular allergy, allergic rhinoconjunctivitis, urticaria, angioedema, and severe asthma. She is also the convenor of the Master’s in Allergic Diseases program at Western Sydney University — the first postgraduate course of its kind in Australia.
Specialty
-
Disclosures
I have received honoria and travel support for presentations on HAE from CSL Nehring.
I have received fees for advisory board participation from CSL Behring, Pharvaris, Takeda, Intellia, KalVista

About Mathias Sulk
–
Specialty
-
Disclosures
-

About Maria Bova
bovamaria@virgilio.it
maria.bova@aocardarelli.it
tel. 0039 /3383329336Maria Bova graduated summa cum laude in 2001 with an MD degree from the University of
Naples. She received a specialization in Allergy and Clinical Immunology in 2005 at the
University of Naples. During this period she spent some months as a Postdoctoral Fellow
at the Division of Allergy and Clinical Immunology, Johns Hopkins University, Baltimore,
USA. In 2009 she received a PhD in clinical and experimental pathophysiology from the
University of Naples focused on treating patients with hereditary angioedema. From 2006
to 2020 she worked as a Medical Officer in the Internal and Emergency Medicine
department at Villa MaltaHospital Sarno, Salerno, and since 2010 to 2020 she has acted
as a Medical consultant at CISI (Centro Interdipartimentale di Ricerca in Scienze
Immunologiche di Base e Cliniche)- University of Naples Federico II. She is a lecturer in
the Physiopathology of Allergic Diseases for Specialization in Clinical Immunology and
Allergy at University of Naples Federico II, and a general pathology lecturer for the general
practitioner and pediatric nursing registered degree at the University of Naples. Since 2021
she works at Department of Internal Medicine, Allergy and Clinical Immunology Unit,
AORN Antonio Cardarelli, Naples, Italy. Her clinical and research activity is mainly focused
on angioedema and urticaria.
She is part of the board of the EAACI Dermatology Section (in the past term she was
board secretary). She has been involved in many activities of EAACI mentorship
programme.
She has been an investigator on many clinical studies of diagnostic and therapeutic
approaches to angioedema and mastocytosis. She authored about 70 peer reviewed
articles on her research topic.Specialty
Disclosures
No disclosures

About Hon. Associate Professor Dr. Hilary Longhurst
Professor Constance Katelaris is a leading allergist and immunologist based in Sydney. She serves as Professor of Immunology and Allergy at Western Sydney University and as Head of Department and Senior Staff Specialist at Campbelltown Hospital. In addition, she runs a private clinical practice, providing specialist care for children and adults with a wide range of allergic and immunologic conditions.
Professor Katelaris has held numerous leadership roles within professional societies, including presidencies of the Asia Pacific Association of Allergology, Asthma and Clinical Immunology and the Australasian Society of Clinical Immunology and Allergy. She has also been an active member of the World Allergy Organization Board.
Her academic interests include education and clinical research, particularly in ocular allergy, allergic rhinoconjunctivitis, urticaria, angioedema, and severe asthma. She is also the convenor of the Master’s in Allergic Diseases program at Western Sydney University — the first postgraduate course of its kind in Australia.
Specialty
-
Disclosures
-

About H. Henry Li, MD, PhD, FAAAAI
–
Specialty
-
Disclosures
Employment: Institute for Asthma and Allergy; Virant Diagnostics; MedBio Reference Laboratories; IAA Clinical Research; Capitol Infusion Center; MedSultants, LLC Academic Affiliation: George Washington University; Nankai University; Johns Hopkins University. Consultancy/Research funding/Speaker: AdaRx, Argo, Astria, Astra-Zenica, BioCryst, BioMarin, Blueprint, CSL Behring, Intellia, Ionis, Kalvista, Pharming, Pharvaris, Pfizer, Gallaxo-Wellcome, etc.

About Francesca Perego
Title Consultant in Internal Medicine and Geriatrics Current Leadership Role Head of Department of Internal Medicine and Rehabilitation Institution IRCCS ICS Maugeri, Milan – Italy Professional Profile Summary Senior Consultant Physician with extensive experience in Internal Medicine, Geriatrics, and Clinical Research. Currently Head of the Complex Operative Unit of Internal Medicine and Geriatrics and Chief of the Medical Rehabilitation Department at IRCCS ICS Maugeri (Milan). Internationally recognised expert in hereditary and acquired angioedema, principal investigator in multiple phase II–IV clinical trials, and author of over 70 peer-reviewed scientific publications. Current Position October 2022 – Present IRCCS ICS Maugeri, Milan (Accredited Private Healthcare Institute); Head of the Complex Operative Unit of Internal Medicine and Geriatrics; Chief of the Internal Medicine and Rehabilitation Department; Permanent Consultant Contract (Senior Level – A11) Previous Appointments 2019 – 2022 Head of Subacute Care Unit, IRCCS ICS Maugeri, Milan 2018 – 2019 Deputy Head of Unit, Subacute Care, IRCCS ICS Maugeri, Milan 2008 – 2018 Consultant in Internal Medicine and Emergency Medicine, Luigi Sacco Hospital, Milan (Public Healthcare) 2007 – 2008 Consultant in Internal Medicine (Fixed-term), Luigi Sacco Hospital, Milan 2005 – 2007 Freelance Consultant in Internal Medicine, Luigi Sacco Hospital, Milan 2004 – 2005 Emergency Department Physician, Vimercate Hospital Education and Qualifications PhD Biomedical Statistics, University of Milan (70/70) Specialisation Internal Medicine, University of Milan (70/70) MD Degree Medicine and Surgery, University of Milan (110/110 cum laude) Master’s Degree Level I in Healthcare Management, University of Bergamo (110/110 cum laude) Certification Basic Ultrasound Certification (SIUMB) Certification ICH-GCP Certification – Faculty of Pharmaceutical Medicine, Royal College of Physicians (UK) Clinical and Research Expertise Areas Internal Medicine and Geriatrics; Hereditary and Acquired Angioedema; Cardiovascular Autonomic Disorders and Syncope; Clinical Trial Design and Management (Principal Investigator); Diagnostic Ultrasound and Cardiovascular Testing Scientific Societies and Leadership Roles Roles Board Member, Italian Network for Hereditary and Acquired Angioedema (ITACA); Member, ACARE – Angioedema Centres of Reference and Excellence; Member, Scientific Committee of SICOA; Former Regional Councillor, Italian Society of Internal Medicine (SIMI – Lombardy) Selected Publications 1 Cancian M, Perego F, Senter R, Arcoleo F, De Pasquale T, Zoli A, Cicardi M, Zanichelli A. Pediatric angioedema: Essential features and preliminary results from the Hereditary Angioedema Global Registry in Italy. Pediatr Allergy Immunol. 2020 Feb;31 Suppl 24:22-24. doi: 10.1111/pai.13170. 2 Perego F, Gidaro A, Zanichelli A, Cancian M, Arcoleo F, Senter R, Bova M, De Pasquale T, Guarino MD, Lo Pizzo M, Frigerio C, Duca PG, Cicardi M; ITACA. Life expectancy in Italian patients with hereditary angioedema due to C1-inhibitor deficiency. J Allergy Clin Immunol Pract. 2020 Jan 16. doi: 10.1016/j.jaip.2020.01.007. 3 Riedl MA, Maurer M, Bernstein JA, Banerji A, Longhurst HJ, Li HH, Lu P, Hao J, Juethner S, Lumry WR, et al. Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks. Allergy. 2020 Nov;75(11):2879-2887. doi: 10.1111/all.14416. 4 Perego F, De Maria B, Bova M, Petraroli A, Marcelli Cesoni A, De Grazia V, Zingale LC, Porta A, Spadaro G, Dalla Vecchia LA. Analysis of Heart-Rate Variability during Angioedema Attacks in Patients with Hereditary C1-Inhibitor Deficiency. Int J Environ Res Public Health. 2021 Mar 12;18(6):2900. doi: 10.3390/ijerph18062900. 5 Johnston DT, Busse PJ, Riedl MA, Maurer M, Anderson J, Nurse C, Inhaber N, Yu M, Banerji A. Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study. Clin Exp Allergy. 2021 Oct;51(10):1391-1395. doi: 10.1111/cea.13974. 6 Guryanova I, Suffritti C, Parolin D, Zanichelli A, Ishchanka N, Polyakova E, Belevtsev M, Perego F, Cicardi M, Zharankova Y, Konoplya N, Caccia S, Gidaro A. Hereditary angioedema due to C1 inhibitor deficiency in Belarus: epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene. Clin Mol Allergy. 2021 Apr 7;19(1):3. doi: 10.1186/s12948-021-00141-0. 7 De Maria B, Cassetti G, Clementi L, De Grazia V, Parati M, Perego F, Porta A, Dalla Vecchia LA. Autonomic cardiac profile in male and female healthcare professionals with and without preschoolers: differences evidenced by heart rate variability analysis. Sci Rep. 2022 Aug 25;12(1):14499. doi: 10.1038/s41598-022-18744-1. 8 De Maria B, Parati M, Bey Y, Dalla Vecchia LA, Perego F. Cardiovascular Autonomic Nervous System in a Patient With Hereditary Angioedema Affected by COVID-19. Cureus. 2024;16(3):e56449. doi: 10.7759/cureus.56449. 9 Riedl MA, Tachdjian R, Lumry WR, Craig T, Karakaya G, Gelincik A, Stobiecki M, Jacobs JS, Gokmen NM, Reshef A, Gompels MM, Manning ME, Bordone L, Newman KB, Treadwell S, Wang S, Yarlas A, Cohn DM. Efficacy and Safety of Donidalorsen for Hereditary Angioedema. N Engl J Med. 2024 May 31. doi: 10.1056/NEJMoa2402478. 10 Zanichelli A, Cattaneo D, Gidaro A, Senter R, Arcoleo F, Accardo P, Bignardi D, Borrelli P, Colangelo C, De Pasquale T, Firinu D, Perego F, Triggiani M, Spadaro G, Cogliati C, Bizzi E, Popescu Janu V, Guarino MD, Quattrocchi P, Brussino L, Rossi O, Triggianese P, Agolini S, Giardino F, Montinaro V, Cancian M. Assessment of potential drug-drug interactions in patients with hereditary angioedema from the ITACA cohort: simulations from a real-life dataset considering danazol versus berotralstat. Front Pharmacol. 2025 Apr 25;16:1550133. doi: 10.3389/fphar.2025.1550133. 11 Senter R, Zanichelli A, Stefano A, Arcoleo F, Bignardi D, Borrelli P, Cogliati C, Colangelo C, De Pasquale T, Giacco SD, Firinu D, Gidaro A, Pizzo ML, Parente R, Perego F, Petraroli A, Janu VP, Pucci S, Quattrocchi P, Ridolfi I, Rossi O, Ruin F, Spadaro G, Triggianese P, Zoli A, Triggiani M, Cancian M. The Impact of COVID-19 on Patients With Bradykinin-Mediated Angioedema in the ITACA Cohort. Clin Exp Allergy. 2025 May 9. doi: 10.1111/cea.70079. 12 Riedl MA, Bernstein JA, Jacobs JS, Craig T, Banerji A, Perego F, Lumry WR, Wedner HJ, Gierer S, Manning ME, Bordone L, Treadwell S, Lin T, Newman KB, Yarlas A, Cohn DM. Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis. J Allergy Clin Immunol Pract. 2025 Jul 17:S2213-2198(25)00599-9. doi: 10.1016/j.jaip.2025.06.018. 13 De Maria B, Ranucci L, Gino C, Zulueta A, Parati M, Cesoni Marcelli A, Zingale LC, Sideri R, Dalla Vecchia LA and Perego F. Cardiac and vascular autonomic control in patients with hereditary angioedema. Front Physiol. 2025;16:1690915. doi: 10.3389/fphys.2025.1690915. 14 Parati M, Ranucci L, Cesoni Marcelli A, Zingale LC, De Maria B, Gino C, Zulueta A, Sideri R, Gorini A and Perego F. Ecological momentary assessments for patients with hereditary angioedema: a feasibility and acceptability controlled study. Front Digit Health. 2026;7:1693550. doi: 10.3389/fdgth.2025.1693550. 15 De Maria B, Ranucci L, Gino C, Cesoni Marcelli A, Zingale LC, Zulueta A, Dalla Vecchia LA, Gorini A and Perego F. Functional physiological, psychological, and biochemical reactivity to socially evaluated cold pressor test in hereditary angioedema patients (FRoSEn). Front Immunol. 2026;16:1736589. doi: 10.3389/fimmu.2025.1736589. 16 Ranucci L, Perego F, Zulueta A, Gino C, Cesoni Marcelli A, Zingale LC, Dalla Vecchia LA, De Maria B and Gorini A. Behavioural withdrawal during an acute stress test as a marker of psychobiological vulnerability in hereditary angioedema. Front Immunol. 2026;17:1784326. doi: 10.3389/fimmu.2026.1784326. Specialty
Disclosures
No disclosures





